Glycemic control in diabetes has been revolutionized with the recent widespread adoption of glucagon-like peptide-1 (GLP-1) receptor agonists
10.1097/01.hjh.0000500039.08261.4f 142 WanF.MaF.WuJ.QiaoX.ChenM.LiW.et al (2022)
The field needs validated, in vivocompatible flux sensors (O 2 , H 2 O 2 , NO/ONOO ) targeted to matrix/IMS, ER lumen, peroxisomes, plasma-membrane microdomains and nucleus, each with built-in specificity controls and reporting standards (matrix, oxygen tension, m, pH) to disambiguate signalling pulses from damage plateaus
Some cover, some dont, all worry about cost and whether its a sunk investment Hard to say
Yeo TW, Weinberg JB, Lampah DA, Kenangalem E, Bush P, Chen Y, Price RN, Young S, Zhang HY, Millington D, Granger DL, Anstey NM
N., Capdevila, D